Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes

NCT02960659 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Liraglutide
DRUG: Metformin

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]